Drug information provided by: IBM Micromedex
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor injection in children.
No information is available on the relationship of age to the effects of Hemofil® M in the pediatric population. Safety and efficacy have not been established.
Although appropriate studies on the relationship of age to the effects of Advate®, Adynovate®, Eloctate™, Kogenate® FS, Kovaltry®, Novoeight®, and Xyntha® have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have age-related medical problems, which may require caution and an adjustment in the dose for patients receiving Advate®, Adynovate®, Eloctate™, Kogenate® FS, Kovaltry®, Novoeight®, and Xyntha®.
No information is available on the relationship of age to the effects of antihemophilic factor injection in geriatric patients.
Information about this antihemophilic-factor-intravenous-route
||Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.
Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.
Antihemophilic Factor VIII Fc Fusion Protein Recombinant
Antihemophilic Factor (Recombinant) Plasma/Albumin-Free
Antihemophilic Factor VIII (Recombinant) Pegylated
Antihemophilic Factor (Recombinant) Pegylated-aucl
Antihemophilic Factor (Recombinant) Porcine Sequence
Antihemophilic Factor VIII (Recombinant)
Antihemophilic Factor (Recombinant), Glycopegylated-exei
Antihemophilic Factor (Recombinant) Single Chain
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Allergy to hamster or mouse proteins, history of or
von Willebrand disease (blood clotting disorder)—Should not be used in patients with these conditions.
Heart or blood vessel disease—Use with caution. May make these conditions worse.